- Home
- NEUP vs LFWD Comparison
NEUP vs LFWD Comparison
Compare NEUP & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- LFWD
- Stock Information
- Founded
- NEUP 1996
- LFWD 2001
- Country
- NEUP United States
- LFWD Israel
- Employees
- NEUP N/A
- LFWD N/A
- Industry
- NEUP
- LFWD
- Sector
- NEUP
- LFWD
- Exchange
- NEUP Nasdaq
- LFWD NYSE
- Market Cap
- NEUP 12.7M
- LFWD 11.8M
- IPO Year
- NEUP N/A
- LFWD 2014
- Fundamental
- Price
- NEUP $7.01
- LFWD $0.60
- Analyst Decision
- NEUP Strong Buy
- LFWD Strong Buy
- Analyst Count
- NEUP 1
- LFWD 3
- Target Price
- NEUP $21.00
- LFWD $9.00
- AVG Volume (30 Days)
- NEUP 22.3K
- LFWD 1.2M
- Earning Date
- NEUP 08-15-2025
- LFWD 08-14-2025
- Dividend Yield
- NEUP N/A
- LFWD N/A
- EPS Growth
- NEUP N/A
- LFWD N/A
- EPS
- NEUP 0.00
- LFWD N/A
- Revenue
- NEUP $15,662,715.00
- LFWD $25,414,000.00
- Revenue This Year
- NEUP N/A
- LFWD $12.04
- Revenue Next Year
- NEUP N/A
- LFWD $40.58
- P/E Ratio
- NEUP $4,149.50
- LFWD N/A
- Revenue Growth
- NEUP N/A
- LFWD 41.92
- 52 Week Low
- NEUP $2.90
- LFWD $0.50
- 52 Week High
- NEUP $126.00
- LFWD $4.77
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- LFWD 13.67
- Support Level
- NEUP N/A
- LFWD $0.50
- Resistance Level
- NEUP N/A
- LFWD $1.15
- Average True Range (ATR)
- NEUP 0.00
- LFWD 0.09
- MACD
- NEUP 0.00
- LFWD -0.05
- Stochastic Oscillator
- NEUP 0.00
- LFWD 10.79
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.